Watch CBS News

Antiviral Remdesivir begins COVID-19 clinical trial

Remdesivir is the first antiviral to begin clinical trials in the U.S. in the race to end the COVID-19 pandemic.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.